News & Blog
Welcome to the Atelerix News & Blog - warm takes on keeping cells happy without the cold, with company updates & research insights (no frostbite required).
Featured articles
Atelerix launches STORganoid cryo-free preservation solution for complex 3D cell models
Ambient-temperature preservation solution enables reliable storage and shipment of organoids and spheroids, to support growing adoption of New Approach Methodologies […]
Atelerix forms strategic partnership with JH Health Ltd to expand non-cryogenic cell preservation capabilities in the Middle East
Agreement grants JH Health exclusive rights to use and distribute Atelerix’s portfolio of non-cryogenic preservation solutions in the region Expands […]
Two Years On: Stem Cell Therapy Brings Sustained Vision Improvement Thanks to Alginate-Based Delivery
At Atelerix, we’re proud to support pioneering work that translates innovative science into real-world patient impact. A recent clinical milestone […]
Atelerix launches STORganoid cryo-free preservation solution for complex 3D cell models
Ambient-temperature preservation solution enables reliable storage and shipment of organoids and spheroids, to support growing adoption of New Approach Methodologies […]
Atelerix forms strategic partnership with JH Health Ltd to expand non-cryogenic cell preservation capabilities in the Middle East
Agreement grants JH Health exclusive rights to use and distribute Atelerix’s portfolio of non-cryogenic preservation solutions in the region Expands […]
Atelerix’s First Ever Seminar: A Resounding Success
Last month, Atelerix hosted its first-ever customer showcase event at Hauxton House, bringing together partners and collaborators to share how […]
Ready-to-Use Organoids Delivered Worldwide Without Cold Chain Complexity
This week, Atelerix teamed up with Cherry Biotech to explore a simple but powerful question: What if organoids could be […]
Atelerix at WORD+2026: A Celebration of Innovation in Organoids and Organ-on-a-Chip Research
Earlier this month, the Atelerix team had the pleasure of attending WORD+2026, the 4th Annual World Organoid and Organ-on-a-Chip Research […]
Atelerix enters agreement with Cherry Biotech to integrate non-cryogenic transport solutions with advanced organoid models
Partnership brings together proven non-cryogenic biosample preservation technology and advanced organoid models to support growth in preclinical research and biotech […]
Atelerix and Labskin partner to enable long-distance transport of advanced in vitro skin models
Agreement to broaden access, streamline logistics, and reduce variability associated with temperature-sensitive shipping of 3D tissue models, without cryopreservation Joint […]
Atelerix at ELRIG Drug Discovery 2025: Enabling the Future of Cell Research
The Atelerix team were delighted to take part in ELRIG Drug Discovery 2025, held at the ACC in Liverpool on […]
Atelerix signs agreement with CliniSciences to broaden access to cryo-free preservation solutions across Europe and North Africa
Agreement with specialist life science and diagnostic labs distributor expands global operational reach and market penetration New distribution channels to […]
Spotlight on Researchers Using Organoids in Disease Modelling
Organoids have rapidly emerged as one of the most powerful tools in biomedical research. These three-dimensional cellular systems, derived from […]
Atelerix and Rodon Global partner to integrate cryo-free preservation technology into specialist logistics solutions
Initial agreement to incorporate Atelerix’s non-cryogenic cell preservation technology into international freight and logistics services for drug discovery and clinical […]
Overcoming Organoid Preservation Challenges in CRO Workflows
Abstract Contract Research Organisations (CROs) are increasingly adopting organoid models for drug discovery, toxicology, and preclinical testing. These three-dimensional cellular […]
From Lab to Market: Recent Advances and Commercialisation of Organoid Technologies
By Sophie Reay Organoids are three-dimensional (3D) tissue cultures derived from stem cells that self-organise into structures that closely […]
Sunil Shah and Dr Catherine Elton join Atelerix’s Board to drive global commercial expansion
Sunil Shah and Dr Catherine Elton join Atelerix’s Board to drive global commercial expansion  Industry-leaders Sunil Shah (CEO, o2h […]
Mini Organs, Major Impact: How Organoids Are Redefining Drug Development & Personalised Medicine
By Sophie Reay Organoids are miniature, three-dimensional (3D) tissue cultures that mimic the structure and function of specific organs. They […]
